In the Boardroom - Merck KGaA

Filter

Current filters:

Merck KGaA

Popular Filters

80 to 104 of 182 results

Nuevolution appoints Ton Berkien as chief business officer

Nuevolution appoints Ton Berkien as chief business officer

09-12-2013

Denmark-based small molecule lead discovery company Nuevolution A/S has appointed Ton Berkien as Chief…

BoardroomDenmarkEuropeNuevolutionPharmaceutical

ThromboGenics founder Désiré Collen to retire

ThromboGenics founder Désiré Collen to retire

09-12-2013

Belgium-based biopharma firm ThromboGenics (Euronext Brussels: THR: BR) has announced that Désiré Collen…

BelgiumBoardroomEuropePharmaceuticalThromboGenics

Novasep announces Nadege Laborde as new president of its industrial biotech business unit

Novasep announces Nadege Laborde as new president of its industrial biotech business unit

06-12-2013

The France-based biotechnology company Novasep has announced Nadege Laborde as the new president of its…

BiotechnologyBoardroomEuropeNovasep

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

03-12-2013

The UK’s ‘Golden Triangle’ of biotech innovation can compete on the world stage, AstraZeneca (LSE:…

AstraZenecaBoardroomBrilintaInterviewsPharmaceuticalUK

Merck KGaA eighth EPP spin-off to focus on infertility treatment

Merck KGaA eighth EPP spin-off to focus on infertility treatment

02-12-2013

USA-based EMD Serono, one of German drug and chemical group Merck KGaA’s biotechnology subsidiaries,…

BiotechnologyEMD SeronoMerck KGaAMerck SeronoMergers & AcquisitionsReproductiveResearchTocopheRx

Takeda names GSK executive as next chief operating officer

Takeda names GSK executive as next chief operating officer

29-11-2013

Japan’s largest drugmaker, Takeda Pharmaceutical, says that Christophe Weber has been approved at the…

BoardroomManagementPharmaceuticalTakeda Pharmaceuticals

Germany’s Merck invests in further research partnerships in Israel

Germany’s Merck invests in further research partnerships in Israel

26-11-2013

German pharma and chemicals firm Merck KGaA says it is increasingly counting on partnerships with Israeli…

BiotechnologyChanBioFinancialMerck KGaAMetabomedNeurologicalOncologyResearchRest of the World

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

20-11-2013

Privately-held Biopharma GmbH says it has signed an agreement with Merck Serono, the biopharma subsidiary…

Anti-Arthritics/RheumaticsBiopharm GmbHMerck KGaAMerck SeronoPharmaceuticalResearch

Immunologist Yong-Jun Liu named head of research at MedImmune

Immunologist Yong-Jun Liu named head of research at MedImmune

20-11-2013

US-based MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca…

BoardroomImmunologicalsMedImmuneNorth AmericaPharmaceuticalUSA

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

20-11-2013

UK-based biotech company Immunocore has appointed Jonathan Knowles as the new executive chairman of the…

AdaptimmuneBoardroomEuropeImmunocoreOncologyPharmaceuticalUK

Vectura appoints ex-AstraZeneca VP Bruno Angelici as non-executive chairman

Vectura appoints ex-AstraZeneca VP Bruno Angelici as non-executive chairman

20-11-2013

UK-based developer of inhaled therapies Vectura Group (LSE: VEC) has announced the appointment of Bruno…

BoardroomEuropeUKVectura

AmpliPhi Biosciences announces Baxter Phillips as VP of corporate strategy and business development

20-11-2013

US-headquartered biotech company AmpliPhi BioSciences (OTCBB: APHB) has appointed Baxter Phillips III…

AmpliPhi BioSciencesBoardroomNorth AmericaUSA

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

20-11-2013

German privately-owned biopharmaceutical company Affimed Therapeutics has appointed Jens-Peter Marschner…

Affimed TherapeuticsBoardroomEuropeMerck KGaA

Interview: Clinigen’s CEO Peter George on the company’s record growth

Interview: Clinigen’s CEO Peter George on the company’s record growth

15-11-2013

If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.

BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK

Merck KGaA to invest 80 million euros in China pharma production

Merck KGaA to invest 80 million euros in China pharma production

15-11-2013

Germany’s Merck KGaA said this morning that it plans to invest 80 million euros ($106.8 million) in…

Asia-PacificFinancialMerck KGaAMerck SeronoPharmaceuticalProduction

Raft of senior management changes at Bristol-Myers Squibb

Raft of senior management changes at Bristol-Myers Squibb

14-11-2013

To support its ongoing success as a BioPharma leader, US drug major Bristol-Myers Squibb says it is evolving…

BoardroomBristol-Myers SquibbManagementPharmaceutical

Merck KGaA improves guidance with strong third quarter results

Merck KGaA improves guidance with strong third quarter results

14-11-2013

Germany’s Merck KGaA (MRK: DE) has posted solid organic revenue growth of 4.7% for the third quarter…

BiotechnologyErbituxEuropeFinancialMerck KGaAMerck SeronoPharmaceuticalRebif

Former OSI CEO Colin Goddard joins Endocyte board of directors

Former OSI CEO Colin Goddard joins Endocyte board of directors

13-11-2013

US biopharma company Endocyte (Nasdaq: ECYT) has announced that Colin Goddard has joined its board of…

BoardroomEndocyteNorth AmericaPharmaceuticalUSA

Brazil’s MoH partners with Merck Serono to invest $430 million in bio-pharma production

Brazil’s MoH partners with Merck Serono to invest $430 million in bio-pharma production

08-11-2013

The Brazilian Ministry of Health is managing a series of product development partnerships and the selection…

Anti-Arthritics/RheumaticsBionovisBiotechnologyFinancialMerck KGaAMerck SeronoOncologyProductionSouth America

Marc Dunoyer appointed chief financial officer of AstraZeneca

Marc Dunoyer appointed chief financial officer of AstraZeneca

31-10-2013

AstraZeneca today announced that Marc Dunoyer has been appointed chief financial officer and will join…

AstraZenecaBoardroomEuropePharmaceutical

Teva Pharmaceutical says CEO Jeremy Levin has resigned

Teva Pharmaceutical says CEO Jeremy Levin has resigned

30-10-2013

Israel-based Teva Pharmaceutical Industries, say that, despite its recent denials of a rift with its…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Gerhard Schmitz to join Merck KGaA as new head of global accounting

Gerhard Schmitz to join Merck KGaA as new head of global accounting

30-10-2013

Merck KGaA announced today that Gerhard Schmitz will join the pharmaceutical, chemical and life science…

BoardroomEuropeMerck KGaAPharmaceutical

Merck Serono and Selvita collaborate on cancer research

Merck Serono and Selvita collaborate on cancer research

24-10-2013

Merck Serono and Poland-based biotech firm Selvita have entered into a collaboration to jointly discover…

BiotechnologyMerck KGaAMerck SeronoOncologyResearchSelvita

EXPERT VIEW: Talent acquisition at the heart of M&A

EXPERT VIEW: Talent acquisition at the heart of M&A

22-10-2013

Mergers and acquisitions are common – 111 M&As took place in the UK in the second quarter of 2013 alone…

BoardroomInterviewsMergers & AcquisitionsPharmaceutical

80 to 104 of 182 results

Back to top